Instrument Business Outlook Volume 31 - Issue 10

2 Sep 2022

Categories:

Instrument Business Outlook

Table of Contents

IBO Sales Indexes Maintaining Growth Amidst Macroeconomic Challenges
- End-Markets
- Regions
- Product Lines
- Quarterly Forecasts
- Full-Year Forecasts
- Conclusion
Virtual Reality and Augmented Reality Move into the Lab
- Product Highlights & Applications
- Challenges
- Looking Forward
Cost Cutting Comes to the Forefront for Some Life Science Tools Companies
- Making Changes
- Cash Conservation
- The Spring
Executive Briefing
- Olympus Sells Evident to Bain
- Illumina Prevails in FTC Case
- Calibre Scientific Adds to European Chromatography Business
- Dutch Reagent Provider Acquired
Second Quarter Results: Agilent Technologies, Bio-Rad Laboratories, Illumina, PerkinElmer and QIAGEN
- Agilent Technologies Raises Annual Revenue Guidance
- Bio-Rad Laboratories Faces Various Challenges
- Illumina's NextSeq 1000 and 2000 Post Growth
- PerkinElmer’s DAS Segment Posts Strength Across End-Markets and Regions
- QIAGEN’s Genomics/NGS Business Performs Tepidly
IBO Indexes’ Tepid Performance in Tandem with the US Stock Market
- Laboratory Instruments and Products Stock Index
- Diversified Instrumentation Stock Index
- International Stocks
Market Profile: Quantitative NMR
- Leading Vendors
- Largest Markets
- Instrument Cost
Industry Watch
- Food & Beverage
- Government
- Clinical
Region Watch
- China
- Brazil
- Japan
News
- Surface Science
  - Company Announcements
  - Product Introductions
  - Sales & Orders of Note
- Spectroscopy
  - Company Announcements
  - Product Introductions
  - Sales & Orders of Note
- Informatics
  - Company Announcements
  - Product Introductions
  - Sales & Orders of Note
- Process Analysis
  - Company Announcements
  - Product Introductions
  - Sales & Orders of Note
- Bioprocess Analysis
  - Company Announcements
Bottom Line

Attachments

IBO 090122 Issue.pdf